- €306.33m
- €423.73m
- €261.91m
- 87
- 35
- 51
- 61
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 14.17 | ||
PEG Ratio (f) | 1.19 | ||
EPS Growth (f) | 13.47% | ||
Dividend Yield (f) | 2.4% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.34 | ||
Price to Tang. Book | 2.68 | ||
Price to Free Cashflow | 16.68 | ||
Price to Sales | 1.22 | ||
EV to EBITDA | 11.06 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 5.33% | ||
Return on Equity | 4.41% | ||
Operating Margin | 7.6% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 214.16 | 250.1 | 287.33 | 274.63 | 261.91 | 256.74 | 271.59 | 6.88% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +58.37 | +66.78 | +43.33 | -27.48 | -51.51 | +32.88 | +13.47 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Directors
- Stefanie Remmele CSU (43)
- Marcus Wolfinger CMG (53)
- Frank Hiller VSU (54)
- Robert Siegle FID (53)
- Claus Vielsack MGB (53)
- Rolf Vornhagen IND (67)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- November 27th, 2018
- Public Since
- August 25th, 1998
- No. of Employees
- 1,462
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
XETRA
- Shares in Issue
- 12,155,942

- Address
- Gewerbestr. 37, BIRKENFELD, 75217
- Web
- https://www.stratec.com/
- Phone
- +49 708279160
- Contact
- Jan Keppeler
- Auditors
- EBNER STOLZ GMBH & CO. KG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT ST
Upcoming Events for SBS
Q1 2025 Stratec Se Earnings Release
Stratec SE Annual Shareholders Meeting
Stratec Se Annual Shareholders Meeting
Half Year 2025 Stratec Se Earnings Release
Similar to SBS
Aap Implantate AG
XETRA
Bio-Gate AG
XETRA
FAQ
As of Today at 23:27 UTC, shares in Stratec SE are trading at €25.20. This share price information is delayed by 15 minutes.
Shares in Stratec SE last closed at €25.20 and the price had moved by -37.24% over the past 365 days. In terms of relative price strength the Stratec SE share price has underperformed the FTSE Global All Cap Index by -38.81% over the past year.
The overall consensus recommendation for Stratec SE is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Stratec SE dividend yield is 2.18% based on the trailing twelve month period.
Last year, Stratec SE paid a total dividend of €0.55, and it currently has a trailing dividend yield of 2.18%. We do not have any data on when Stratec SE is to next pay dividends.
We do not have data on when Stratec SE is to next pay dividends. The historic dividend yield on Stratec SE shares is currently 2.18%.
To buy shares in Stratec SE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €25.20, shares in Stratec SE had a market capitalisation of €306.33m.
Here are the trading details for Stratec SE:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: SBS
Based on an overall assessment of its quality, value and momentum Stratec SE is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Stratec SE is €38.90. That is 54.37% above the last closing price of €25.20.
Analysts covering Stratec SE currently have a consensus Earnings Per Share (EPS) forecast of €1.57 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stratec SE. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -32.8%.
As of the last closing price of €25.20, shares in Stratec SE were trading -26.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Stratec SE PE ratio based on its reported earnings over the past 12 months is 14.17. The shares last closed at €25.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Stratec SE's management team is headed by:
- Stefanie Remmele - CSU
- Marcus Wolfinger - CMG
- Frank Hiller - VSU
- Robert Siegle - FID
- Claus Vielsack - MGB
- Rolf Vornhagen - IND